Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P01130: Variant p.Glu201Lys

Low-density lipoprotein receptor
Gene: LDLR
Feedback?
Variant information Variant position: help 201 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Glutamate (E) to Lysine (K) at position 201 (E201K, p.Glu201Lys). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and acidic (E) to large size and basic (K) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In FHCL1. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 201 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 860 The length of the canonical sequence.
Location on the sequence: help PQRCRGLYVFQGDSSPCSAF E FHCLSGECIHSSWRCDGGPD The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         PQRCRGLYVFQ--GDSSPCSAFEFHCLSGECIHSSWRCDGGPD

Mouse                         PQNCQGRDTASK-GVSSPCSSLEFHCGSSECIHRSWVCDGE

Rat                           PQNCGAEDTAAE-VVSSPCSSLEFHCGSSECIHRSWVCDGA

Bovine                        PKHCGTPHPSGPLQDNNPCSALEFHCGSGECIHSSWHCDHD
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 22 – 860 Low-density lipoprotein receptor
Topological domain 22 – 788 Extracellular
Domain 195 – 233 LDL-receptor class A 5
Region 146 – 233 Binding to Getah virus E1-E2 spike glycoproteins
Disulfide bond 197 – 209
Alternative sequence 105 – 272 Missing. In isoform 3.
Alternative sequence 106 – 232 Missing. In isoform 2.
Mutagenesis 208 – 208 E -> R. Partial loss of binding to getah virus E2-E1 spike glycoproteins.
Mutagenesis 214 – 214 W -> I. Partial loss of binding to getah virus E2-E1 spike glycoproteins.
Mutagenesis 217 – 217 D -> K. Partial loss of binding to getah virus E2-E1 spike glycoproteins.
Beta strand 201 – 204



Literature citations
Analysis of sequence variations in low-density lipoprotein receptor gene among Malaysian patients with familial hypercholesterolemia.
Al-Khateeb A.; Zahri M.K.; Mohamed M.S.; Sasongko T.H.; Ibrahim S.; Yusof Z.; Zilfalil B.A.;
BMC Med. Genet. 12:40-40(2011)
Cited for: VARIANTS FHCL1 HIS-139; LYS-201; SER-255; ASN-304 AND GLY-471;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.